MENU

Products

TOOLS Cell Counting (CCK-8) kit

Data sheet MSDS
TOOLS Cell Counting (CCK-8) kit is a ready-to-use solution without premixing of components. Cell Counting Kit-8, being nonradioactive, allows sensitive colorimetric assays for the determination of the number of viable cells in cell proliferation and cytotoxicity assays. WST-8 is reduced by dehydrogenases in cells to give a yellow colored product (formazan), which is soluble in the tissue culture medium. The amount of the formazan dye generated by the activity of dehydrogenases in cells is directly proportional to the number of living cells. The detection sensitivity of CCK-8 is higher than other tetrazolium salts such as MTT, XTT, MTS or WST-1.

 

 

No. Size Price Qty
TEN-CCK8 5ml (500 assays) $160.00
TEN-CCK8-100 100ml (10000 assays) $1,655.00
The price does not include shipping fee and tax. ORDER
Features
  • One-bottle Solution: no premixing of components is required.
  • Lower Toxicity: cells can be use for others experiments after CCK-8 assay.
  • High Sensitivity: CCK-8 is the highest sensitive dye for cell-based assay.
  • Many Applications: Can be used on cell proliferation, cell toxicity, drug selection experiments.
  • Data Repeatability: results of the data has been confirmed many times and can be repeated.
 ...............................................................................................................
Theory

    

 

 

Comparison between CCK-8 and other cell proliferation /cytotoxicity assays.
Method
MTT
XTT
WST-1
CCK-8
Sensitivity
Low
Medium
Medium
High
Stability
Medium
Low
Medium
High
Cytotoxicity
High
Low
Low
Lower
Procedure Time
Long 
Short
Short
Lower
Detecting Time
560-600nm
420-480nm
420-480nm
430-490nm


Comparison of sensitivity between CCK-8 and MTT test



 

  1. Wu CP et al. "Sitravatinib Sensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs." Cancers (Basel). (2020)

  2. Wu CP et al. "MY-5445, a phosphodiesterase type 5 inhibitor, resensitizes ABCG2-overexpressing multidrug-resistant cancer cells to cytotoxic anticancer drugs." Am J Cancer Res. (2020) 

  3. Tang KW et al. "Design, Synthesis, and Anti-Bacterial Evaluation of Triazolyl-Pterostilbene Derivatives." Int J Mol Sci. (2019)

  4. Wu CP et al. "SIS3, a specific inhibitor of Smad3 reverses ABCB1-and ABCG2-mediated multidrug resistance in cancer cell lines." Cancer letters 433 (2018): 259-272.

  5. Hsiao SH et al. "The FLT3 inhibitor midostaurin selectively resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents." Cancer letters 445 (2019): 34-44.

  6. Wu CP et al. "Avapritinib, a selective inhibitor of KIT and PDGFRα reverses ABCB1 and ABCG2-mediated multidrug resistance in cancer cell lines." Molecular pharmaceutics (2019).

  7. Wu CP et al. "Human ATP-binding cassette transporters ABCB1 and ABCG2 confer resistance to histone deacetylase 6 inhibitor ricolinostat (ACY-1215) in cancer cell lines." Biochemical pharmacology 155 (2018): 316-325.

  8. Hsiao SH et al. The positive inotropic agent DPI-201106 selectively reverses ABCB1-mediated multidrug resistance in cancer cell lines." Cancer letters 434 (2018): 81-90.

  9. Wu CP, Lusvarghi S, Hsiao SH, Liu TC, Li YQ, Huang YH, Hung TH, Ambudkar SV. Licochalcone A Selectively Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs. J Nat Prod. 2020 May 22;83(5):1461-1472.

  10. Wu CP, Hung TH, Hsiao SH, Huang YH, Hung LC, Yu YJ, Chang YT, Wang SP, Wu YS. Erdafitinib Resensitizes ABCB1-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs. Cancers (Basel). 2020 May 26;12(6):1366.

  11. Wu CP, Hung CY, Lusvarghi S, Huang YH, Tseng PJ, Hung TH, Yu JS, Ambudkar SV. Overexpression of ABCB1 and ABCG2 contributes to reduced efficacy of the PI3K/mTOR inhibitor samotolisib (LY3023414) in cancer cell lines. Biochem Pharmacol. 2020 Oct;180:114137.

  12. Wu CP, Hung CY, Lusvarghi S, Chang YF, Hsiao SH, Huang YH, Hung TH, Yu JS, Ambudkar SV. Overexpression of Human ABCB1 and ABCG2 Reduces the Susceptibility of Cancer Cells to the Histone Deacetylase 6-Specific Inhibitor Citarinostat. Int J Mol Sci. 2021 Mar 5;22(5):2592.

  13. ​Wu CP, Murakami M, Wu YS, Chi YC, Hsiao SH, Huang YH, Hung TH, Ambudkar SV. Branebrutinib (BMS-986195), a Bruton's Tyrosine Kinase Inhibitor, Resensitizes P-Glycoprotein-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Agents. Front Cell Dev Biol. 2021 Jul 19;9:699571.

  14. ​Wu CP, Hung TH, Lusvarghi S, Chu YH, Hsiao SH, Huang YH, Chang YT, Ambudkar SV. The third-generation EGFR inhibitor almonertinib (HS-10296) resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs. Biochem Pharmacol. 2021 Jun;188:114516.

  15. Wu CP, Li YQ, Hung TH, Chang YT, Huang YH, Wu YS. Sophoraflavanone G Resensitizes ABCG2-Overexpressing Multidrug-Resistant Non-Small-Cell Lung Cancer Cells to Chemotherapeutic Drugs. J Nat Prod. 2021 Sep 24;84(9):2544-2553.

  16. ​Wu CP, Li YQ, Chi YC, Huang YH, Hung TH, Wu YS. The Second-Generation PIM Kinase Inhibitor TP-3654 Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs. Int J Mol Sci. 2021 Aug 30;22(17):9440.

  17. Hung CT, Su TH, Chen YT, Wu YF, Chen YT, Lin SJ, Lin SL, Yang KC. Targeting ER protein TXNDC5 in hepatic stellate cell mitigates liver fibrosis by repressing non-canonical TGFβ signalling. Gut. 2021 Dec 21:gutjnl-2021-325065.